Creates provisions relating to alternative therapies

HB 1830 creates a legal framework allowing adults aged 21 and older to use psilocybin for therapeutic purposes if they have specific conditions like PTSD, depression, substance use disorders, or require end-of-life care. To qualify, individuals must enroll in a clinical trial or be declined due to lack of space, obtain a physician's certification, and have their psilocybin tested by a state-licensed laboratory before use. The bill also provides immunity from civil and criminal penalties for patients, assistants, and licensed laboratories involved in the process, while prohibiting state agencies from sharing participant data with the federal government. Additionally, the legislation allocates two million dollars in grants for research and requires the Department of Health and Senior Services to submit annual reports on the program's implementation and outcomes.